Potentiation of in vitro ara-C cytotoxicity by ribonucleotide reductase inhibitors, cyclin-dependent kinase modulators and the DNA repair inhibitor aphidicolin in paediatric acute myeloid leukaemia-Reference-Cited by-同舟云学术

Potentiation of in vitro ara-C cytotoxicity by ribonucleotide reductase inhibitors, cyclin-dependent kinase modulators and the DNA repair inhibitor aphidicolin in paediatric acute myeloid leukaemia

Published:2005-10 Issue:2 Volume:131 Page:219-222
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hubeek I.,Peters G. J.,Broekhuizen A. J. F.,Sargent J.,Gibson B. E. S.,Creutzig U.,Kaspers G. J. L.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2005.05760.x/fullpdf

Reference12 articles.

1. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

2. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.

3. Modulation of Cytarabine Induced Cytotoxicity Using Novel Deoxynucleoside Analogs in the HL60 Cell Line

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA Targeting in Acute Myeloid Leukemia;ACS Pharmacology & Translational Science;2020-10-12

2. Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation;Annals of Hematology;2019-06-14

3. Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs;Oncotarget;2016-05-20

4. Assaying pharmacodynamic endpoints with targeted therapy: Flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemia;PROTEOMICS;2010-11-26

5. Cladribine in the Treatment of Acute Myeloid Leukemia: A Single-Institution Experience;Clinical Lymphoma and Myeloma;2009-08